Indicated for the treatment of Chronic Hepatitis B virus (HBV) infection in adults and adolescents (12+ years). It is the preferred regimen for patients with: Bone disease (osteopenia/osteoporosis). Renal impairment (kidney issues). History of long-term treatment with other antivirals.

Dosage and administration

Standard Dosage: One tablet (25 mg) taken orally once daily. ⚠️ Administration Instructions: 🍲 Take with food. Food enhances bioavailability. Do not discontinue abruptly. Stopping the medication can cause a severe acute exacerbation of Hepatitis B.

Hypersensitivity to Tenofovir Alafenamide. Decompensated liver disease (Child-Pugh B or C). Breastfeeding. HIV Co-infection Warning: HIV antibody testing should be offered to all patients before starting therapy. Tafnat alone is not adequate for HIV treatment.

Tafnat has an excellent safety profile. Mild reactions may include: Headache. Abdominal pain. Fatigue. Cough. It demonstrates significantly less impact on bone mineral density and renal function markers compared to TDF.

Tafnat — Tenofovir Alafenamide 25 mg, 30 pcs, Natco

100% original product

Active ingredient

Tenofovir Alafenamide

Manufacturer

Natco

Dosage 25 mg

Dosage form Tablets

Tablets per pack 30

Tafnat (Tenofovir Alafenamide) 25 mg Tablets (30 Count)

Name: Tafnat
Brand: Natco
SKU: PROD-56
Price: 1318 UAH
Availability: InStock

1318₴ ~~1758₴~~ -25%

Tafnat is a cutting-edge antiviral drug for Hepatitis B treatment. Active ingredient: Tenofovir Alafenamide (25 mg), known as TAF.

Manufacturer: Natco Pharma (India). A premium generic version of Vemlidy.

The Natco Advantage:

Manufactured by one of the most trusted pharmaceutical companies in the world. Tafnat is a "prodrug" that transports the active substance directly into hepatocytes (liver cells). This allows for a minimal dose (25 mg) to be highly effective while sparing the kidneys and bones from toxicity associated with older treatments.

✅ Safety Profile: The best option for long-term lifelong therapy.

Indicated for the treatment of Chronic Hepatitis B virus (HBV) infection in adults and adolescents (12+ years).

It is the preferred regimen for patients with:

Bone disease (osteopenia/osteoporosis).
Renal impairment (kidney issues).
History of long-term treatment with other antivirals.

Standard Dosage: One tablet (25 mg) taken orally once daily.

⚠️ Administration Instructions:

🍲 Take with food. Food enhances bioavailability.
Do not discontinue abruptly. Stopping the medication can cause a severe acute exacerbation of Hepatitis B.

Hypersensitivity to Tenofovir Alafenamide.
Decompensated liver disease (Child-Pugh B or C).
Breastfeeding.
HIV Co-infection Warning: HIV antibody testing should be offered to all patients before starting therapy. Tafnat alone is not adequate for HIV treatment.

Tafnat has an excellent safety profile. Mild reactions may include:

Headache.
Abdominal pain.
Fatigue.
Cough.

It demonstrates significantly less impact on bone mineral density and renal function markers compared to TDF.

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 12.03.2026